NASDAQ:AARD

Aardvark Therapeutics . Common Stock Stock Insider Trading

*Your capital is at risk

$7.56

-0.340 (-4.30%)

At Close: Aug 10, 2026

Aardvark Therapeutics . Common Stock Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 20.48M and sold 28.52M AARD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	20.48M shares
● Sell	28.52M shares
93% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 14, 2025 Buy	Common Stock C-Conversion	Chi Jeffrey Director	Director	133 364 Value: $1.77M
Feb 14, 2025 Sell	Series C Convertible Preferred Stock C-Conversion	Decheng Capital Global Life Sciences Fund Iv, L.p. 10 Percent Owner	10% Owner	2 825 337 Value: $0
Feb 14, 2025 Buy	Common Stock P-Purchase	Cormorant Asset Management, Lp Former 10% Owner	Other	187 500 Value: $3.00M
Feb 14, 2025 Buy	Common Stock C-Conversion	Cormorant Asset Management, Lp Former 10% Owner	Other	800 189 Value: $10.6M
Feb 14, 2025 Sell	Series C Convertible Preferred Stock C-Conversion	Cormorant Asset Management, Lp Former 10% Owner	Other	6 780 810 Value: $0
Feb 14, 2025 Sell	Series A Convertible Preferred Stock C-Conversion	Lee Tien-li Chief Executive Officer	CEO / President	350 002 Value: $0
Feb 14, 2025 Buy	Common Stock C-Conversion	Lee Tien-li Chief Executive Officer	CEO / President	41 303 Value: $549.3K
Feb 14, 2025 Buy	Common Stock C-Conversion	Decheng Capital Global Life Sciences Fund Iv, L.p. 10 Percent Owner	10% Owner	333 412 Value: $4.43M
Feb 14, 2025 Buy	Common Stock P-Purchase	Decheng Capital Global Life Sciences Fund Iv, L.p. 10 Percent Owner	10% Owner	625 000 Value: $10.0M
Feb 14, 2025 Buy	Common Stock C-Conversion	Decheng Capital Global Life Sciences Fund Iv, L.p. 10 Percent Owner	10% Owner	2 333 887 Value: $31.0M
Feb 14, 2025 Buy	Common Stock P-Purchase	Decheng Capital Global Life Sciences Fund Iv, L.p. 10 Percent Owner	10% Owner	625 000 Value: $10.0M
Feb 12, 2025 Buy	Series C Convertible Preferred Stock	Cormorant Asset Management, Lp 10 Percent Owner	10% Owner	6 780 810 Value: $51.3M
Feb 12, 2025 Buy	Common Stock J-Other	Tong Victor Edward Jr Insider	Other	0 Value: $0
Feb 12, 2025 Buy	Stock Option (Right to Buy)	Lee Tien-li Chief Executive Officer	CEO / President	59 004 Value: $250.2K
Feb 12, 2025 Buy	Series A Convertible Preferred Stock	Lee Tien-li Chief Executive Officer	CEO / President	41 303 Value: $312.3K
Feb 12, 2025 Buy	Common Stock	Lee Tien-li Chief Executive Officer	CEO / President	0 Value: $0
Feb 12, 2025 Buy	Common Stock	Lee Tien-li Chief Executive Officer	CEO / President	0 Value: $0
Feb 12, 2025 Buy	Series C Convertible Preferred Stock	Chi Jeffrey Director	Director	133 364 Value: $1.01M
Feb 12, 2025 Buy	Stock Option (Right to Buy)	Jaiman Manasi Chief Medical Officer	Officer	177 012 Value: $750.5K
Feb 12, 2025 Buy	Series C Convertible Preferred Stock	Decheng Capital Global Life Sciences Fund Iv, L.p. 10 Percent Owner	10% Owner	333 412 Value: $2.52M
Feb 12, 2025 Buy	Series A Convertible Preferred Stock	Vickers Venture Fund Vi Pte Ltd 10 Percent Owner	10% Owner	1 637 411 Value: $12.4M
Feb 12, 2025 Buy	Stock Option (Right to Buy)	Jones Bryan Chief Operating Officer	C-Suite Officer	35 402 Value: $108.0K
Feb 12, 2025 Buy	Stock Option (Right to Buy)	Jones Bryan Chief Operating Officer	C-Suite Officer	5 900 Value: $8K
Feb 12, 2025 Buy	Stock Option (Right to Buy)	Jones Bryan Chief Operating Officer	C-Suite Officer	35 402 Value: $108.3K
Feb 12, 2025 Buy	Stock Option (Right to Buy)	Jones Bryan Chief Operating Officer	C-Suite Officer	41 302 Value: $175.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks